VSEE HEALTH, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 09/03/25 | FY 12/31/24 | FY 09/30/24 | FY 06/30/24 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.6M | — | $10.4M | — | — |
| Cost of revenue | $7.3M | — | $3.2M | — | — |
| Gross profit | $7.4M | — | $7.2M | — | — |
| Operating expenses | $16.9M | — | $69.3M | — | — |
| Operating income | -$9.6M | — | -$62.2M | — | — |
| Interest expense | $2.8M | — | $211,459 | — | — |
| Pretax income | -$14.6M | — | -$59.3M | — | — |
| Income tax expense | $68,426 | — | -$1.6M | — | — |
| Net income | -$14.7M | — | -$57.7M | — | — |
| Balance Sheet | |||||
| Cash and equivalents | $5.3M | — | $326,115 | — | — |
| Current assets | $8.4M | — | $3.0M | $4.4M | $3.1M |
| Total assets | $22.4M | — | $20.0M | $22.3M | $78.6M |
| Current liabilities | $16.2M | — | $19.0M | $20.2M | $24.1M |
| Total liabilities | $17.0M | — | $20.0M | $21.4M | $25.5M |
| Total debt | — | $304,288 | — | — | — |
| Stockholders' equity | $5.5M | — | -$18,488 | $933,128 | $53.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$3.4M | — | -$5.8M | — | — |
| Depreciation and amortization | $33,614 | — | $17,834 | — | — |
| Stock-based compensation | $1.1M | — | $896,537 | — | — |
| Capital expenditure | $29,928 | — | $55,267 | — | — |
| Free cash flow | -$3.5M | — | -$5.8M | — | — |
| Share repurchases | $44 | — | $5,150 | — | — |
| Impairments | $0 | — | $56.7M | — | — |
Shares outstanding 48.6M · Free float 74.3%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.